Serum Prostatic Specific Antigen Changes After Bipolar and Monopolar TURP

Study Overview
=================
Brief Summary
-----------------
To use PSA levels after bipolar and monopolar transurethral resection of the benign prostatic hyperplasia as an indicator of the quality of resection .

Detailed Description
-----------------
PSA is a protein produced from the prostate epithelium and secreted in semen in huge amounts , small amount find its way to the circulation ,its function is to allow mobility of the sperms by interacting with the Semenogelin . clinical BPH can be defined as prostate adenoma/adenomata, causing a varying degree of BOO, which may eventually cause harm to the patients ,Treatment of this condition varies from conservative, medical and surgical depending on factors related to the patient and the surgeon preference . The early reports of minimally invasive treatment of the prostate dated back to 1937, since then and remarkable development is noticed . TURP is the golden treatment in the BPH . Studies compare between the methods according the blood transfusion , operation time retention after catheter removal , urethral complications , TUR syndrome and hospital-stay which show that bipolar is better. To our knowledge after few studies compare between the techniques according PSA also these studies show weakness in their statistically analysis with no difference between the methods .investigators aim is to study the effect of the operations on PSA levels as an indicator of the quality of resection.

Official Title
-----------------
Serum Prostatic Specific Antigen (PSA) Changes After Bipolar and Monopolar Transurethral Resection of the Benign Prostatic Hyperplasia, a Randomized Controlled Study.

Conditions
-----------------
PSA Changes After TURP

Intervention / Treatment
-----------------
* Procedure: TURP


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients agreeing to participate, clinically fit, age from 50 to 80 years with LUTS related to benign prostate enlargement with no neurological disorder Exclusion Criteria: Prostate cancer Previous urethral or prostate surgery Neurogenic bladder Urethral stricture Patient unfit for surgery

Ages Eligible for Study
-----------------
Minimum Age: 50 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Bipolar TURP<br>Patients thats will undergo bipolar TURP | Procedure: TURP<br>* Bipolar and monopolar transurethral resection of the benign prostatic hyperplasia<br>|
| Active Comparator: Monopolar TURP<br>Patients thats will undergo monopolar TURP | Procedure: TURP<br>* Bipolar and monopolar transurethral resection of the benign prostatic hyperplasia<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| serum PSA changes after bipolar and monopolar transurethral resection of the benign prostatic hyperplasia | To use PSA levels changes after both techniques (bipolar and monopolar transurethral resection of the benign prostatic hyperplasia)as an indicator of the quality of resection | within one month after intervention | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| International Prostate Symptom Score | International Prostate Symptom Score after bipolar and monopolar transurethral resection of the benign prostatic hyperplasia | within one month after intervention |